<code id='FB3663981C'></code><style id='FB3663981C'></style>
    • <acronym id='FB3663981C'></acronym>
      <center id='FB3663981C'><center id='FB3663981C'><tfoot id='FB3663981C'></tfoot></center><abbr id='FB3663981C'><dir id='FB3663981C'><tfoot id='FB3663981C'></tfoot><noframes id='FB3663981C'>

    • <optgroup id='FB3663981C'><strike id='FB3663981C'><sup id='FB3663981C'></sup></strike><code id='FB3663981C'></code></optgroup>
        1. <b id='FB3663981C'><label id='FB3663981C'><select id='FB3663981C'><dt id='FB3663981C'><span id='FB3663981C'></span></dt></select></label></b><u id='FB3663981C'></u>
          <i id='FB3663981C'><strike id='FB3663981C'><tt id='FB3663981C'><pre id='FB3663981C'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          fashion

          author:explore    - browse:54588
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus